CANCER IMMUNOLOGY IMMUNOTHERAPY

期刊名
CANCER IMMUNOLOGY IMMUNOTHERAPY

CANCER IMMUNOL IMMUN

ISSN / eISSN
0340-7004 / 1432-0851
目标和范围
Cancer Immunology, Immunotherapy has the basic aim of keeping readers informed of the latest research results in the fields of oncology and immunology. As knowledge expands, the scope of the journal has broadened to include more of the progress being made in the areas of biology concerned with biological response modifiers. This helps keep readers up to date on the latest advances in our understanding of tumor-host interactions.

The journal publishes short editorials including "position papers," general reviews, original articles, and short communications, providing a forum for the most current experimental and clinical advances in tumor immunology.
研究方向

免疫学

肿瘤学

CiteScore
10.50 查看趋势图
CiteScore 学科排名
类别 分区 排名
Medicine - Oncology Q1 #53/404
Medicine - Cancer Research Q1 #46/230
Medicine - Immunology and Allergy Q1 #48/233
Medicine - Immunology Q1 #50/236
Web of Science 核心收藏夹
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
类别 (Journal Citation Reports 2024) 分区
IMMUNOLOGY Q2
ONCOLOGY Q1
H-index
104
出版国家或地区
UNITED STATES
出版商
Springer Berlin Heidelberg
出版周期
Monthly
出版年份
1976
年文章数
207
Open Access
NO
通讯方式
SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013
认证评论
注: 认证评论选取于全球各个学术评论平台和社交媒体。
The speed is exceptionally slow.
2021-03-01

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started